These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 29024007)

  • 21. Thyroid hormone resistance syndrome: correlation of dominant negative activity and location of mutations.
    Nagaya T; Eberhardt NL; Jameson JL
    J Clin Endocrinol Metab; 1993 Oct; 77(4):982-90. PubMed ID: 8408475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An arginine to histidine mutation in codon 315 of the c-erbA beta thyroid hormone receptor in a kindred with generalized resistance to thyroid hormones results in a receptor with significant 3,5,3'-triiodothyronine binding activity.
    Cugini CD; Leidy JW; Chertow BS; Bérard J; Bradley WE; Menke JB; Hao EH; Usala SJ
    J Clin Endocrinol Metab; 1992 May; 74(5):1164-70. PubMed ID: 1314846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular modeling revealed that ligand dissociation from thyroid hormone receptors is affected by receptor heterodimerization.
    Zhuang S; Bao L; Linhananta A; Liu W
    J Mol Graph Model; 2013 Jul; 44():155-60. PubMed ID: 23831995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ligand- and nuclear factor-dependent change in hydrophobicity of thyroid hormone beta1 receptor.
    Sakurai A; Katai M; Miyamoto T; Ichikawa K; Hashizume K
    Thyroid; 1998 Apr; 8(4):343-52. PubMed ID: 9588500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential sensitivity of thyroid hormone receptor isoform homodimers and mutant heterodimers to hormone-induced dissociation from deoxyribonucleic acid: its role in dominant negative action.
    Zhu XG; McPhie P; Cheng SY
    Endocrinology; 1997 Apr; 138(4):1456-63. PubMed ID: 9075702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential capacity of wild type promoter elements for binding and trans-activation by retinoic acid and thyroid hormone receptors.
    Williams GR; Harney JW; Moore DD; Larsen PR; Brent GA
    Mol Endocrinol; 1992 Oct; 6(10):1527-37. PubMed ID: 1333048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conformational changes of human beta 1 thyroid hormone receptor induced by binding of 3,3',5-triiodo-L-thyronine.
    Bhat MK; Parkison C; McPhie P; Liang CM; Cheng SY
    Biochem Biophys Res Commun; 1993 Aug; 195(1):385-92. PubMed ID: 8363616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel natural mutation in the thyroid hormone receptor defines a dual functional domain that exchanges nuclear receptor corepressors and coactivators.
    Tagami T; Gu WX; Peairs PT; West BL; Jameson JL
    Mol Endocrinol; 1998 Dec; 12(12):1888-902. PubMed ID: 9849963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isoform variable action among thyroid hormone receptor mutants provides insight into pituitary resistance to thyroid hormone.
    Safer JD; Langlois MF; Cohen R; Monden T; John-Hope D; Madura J; Hollenberg AN; Wondisford FE
    Mol Endocrinol; 1997 Jan; 11(1):16-26. PubMed ID: 8994184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generalized thyroid hormone resistance: identification of an arginine to cystine mutation in codon 315 of the c-erb A beta thyroid hormone receptor.
    Burman KD; Djuh YY; Nicholson D; Rhooms P; Wartofsky L; Fein HG; Usala SJ; Hao EH; Bradley WE; Berard J
    J Endocrinol Invest; 1992 Sep; 15(8):573-9. PubMed ID: 1358935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thyroid hormone receptor binds with unique properties to response elements that contain hexamer domains in an inverted palindrome arrangement.
    Williams GR; Zavacki AM; Harney JW; Brent GA
    Endocrinology; 1994 Apr; 134(4):1888-96. PubMed ID: 8137757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormone selectivity in thyroid hormone receptors.
    Wagner RL; Huber BR; Shiau AK; Kelly A; Cunha Lima ST; Scanlan TS; Apriletti JW; Baxter JD; West BL; Fletterick RJ
    Mol Endocrinol; 2001 Mar; 15(3):398-410. PubMed ID: 11222741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dominant negative transcriptional regulation by a mutant thyroid hormone receptor-beta in a family with generalized resistance to thyroid hormone.
    Sakurai A; Miyamoto T; Refetoff S; DeGroot LJ
    Mol Endocrinol; 1990 Dec; 4(12):1988-94. PubMed ID: 2082193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a thyroid hormone response element in the mouse myogenin gene: characterization of the thyroid hormone and retinoid X receptor heterodimeric binding site.
    Downes M; Griggs R; Atkins A; Olson EN; Muscat GE
    Cell Growth Differ; 1993 Nov; 4(11):901-9. PubMed ID: 8297796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The molecular basis of thyroid hormone action.
    Brent GA
    N Engl J Med; 1994 Sep; 331(13):847-53. PubMed ID: 8078532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Understanding the molecular mechanism of dominant negative action of mutant thyroid hormone beta 1-receptors: the important role of the wild-type/mutant receptor heterodimer.
    Zhu XG; Yu CL; McPhie P; Wong R; Cheng SY
    Endocrinology; 1996 Feb; 137(2):712-21. PubMed ID: 8593822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel resistance to thyroid hormone associated with a new mutation (T329N) in the thyroid hormone receptor beta gene.
    Sarkissian G; Dace A; Mesmacque A; Bony-Trifunovic H; Malezet-Desmoulins C; Torresani J; Margotat A
    Thyroid; 1999 Feb; 9(2):165-71. PubMed ID: 10090317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dominant and nondominant negative C-erbA beta 1 receptors associated with thyroid hormone resistance syndromes augment 12-O-tetradecanoyl-phorbol-13-acetate induction of the collagenase promoter and exhibit defective 3,5,3'-triiodothyronine-mediated repression.
    Ways DK; Qin W; Cook P; Parker PJ; Menke JB; Hao E; Smith AM; Jones C; Hershman JM; Geffner ME
    Mol Endocrinol; 1993 Sep; 7(9):1112-20. PubMed ID: 8247013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The thyroid hormone receptor variant alpha2 is a weak antagonist because it is deficient in interactions with nuclear receptor corepressors.
    Tagami T; Kopp P; Johnson W; Arseven OK; Jameson JL
    Endocrinology; 1998 May; 139(5):2535-44. PubMed ID: 9564869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of a novel method for the comparison of DNA binding parameters of the two human thyroid hormone receptor subtypes hTR alpha 1 and hTR beta 1.
    Carlsson B; Ahola H; Häggblad J
    J Recept Signal Transduct Res; 1997; 17(1-3):355-71. PubMed ID: 9029501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.